Skip to main content

SurveyMonkey and COVID Near You Announce Collaboration to Accelerate Coronavirus Research

SAN MATEO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) today announced a new collaboration with COVID Near You, a joint project of Boston Children’s Hospital and the Harvard Medical School, to accelerate critical coronavirus research efforts across the United States. COVID Near You will use the scale and reach of millions of daily survey respondents through SurveyMonkey to collect essential community data on the current global crisis.
Created by epidemiologists at Boston Children’s Hospital and Harvard Medical School, COVID Near You uses crowdsourced data to help citizens and public health agencies identify current and potential hotspots for COVID-19. By leveraging SurveyMonkey, COVID Near You will get a steady stream of diverse respondents across the United States, providing greatly expanded reach in understanding the spread of COVID-19 and the rapid changes roiling daily life across the world.“COVID Near You is thrilled to collaborate with SurveyMonkey to increase by an order of magnitude the number of people we can invite to share their experiences with and feelings about coronavirus,” said John Brownstein, Ph.D., chief innovation officer at Boston Children’s Hospital and Harvard Medical School Professor. “The scale of data made possible by this innovative collaboration will directly inform public health decision making, resource allocation, and policy at the national and local levels.” “Having access to high-quality data in the fast-moving and quickly evolving coronavirus crisis is a critical component for public health leaders as they gain visibility on how COVID-19 is changing their communities,” said Jon Cohen, chief research officer at SurveyMonkey. “We’re excited our research tools and expertise will accelerate the essential work COVID Near You is doing in the fight against the coronavirus.”The collaboration launches today through a specialized survey designed by COVID Near You and deployed on the SurveyMonkey platform. Aggregate data will be reported regularly on the COVID Near You and SurveyMonkey websites and made available to media outlets, public health officials and the Center for Disease Control.For more information on how SurveyMonkey is supporting its customers and community through the coronavirus crisis, please visit here.About SurveyMonkey
SurveyMonkey is a leading global survey software company on a mission to power the curious. The company’s platform empowers over 17 million active users to measure and understand feedback from employees, customers, website and app users, and the market. SurveyMonkey’s products, enterprise solutions and integrations enable more than 335,000 organizations to solve daily challenges, from delivering better customer experiences to increasing employee retention. With SurveyMonkey, organizations around the world can transform feedback into business intelligence that drives growth and innovation.
About COVID Near You
Created by epidemiologists and software developers at Harvard, Boston Children’s Hospital, and volunteers across the technology industry, COVID Near You uses crowdsourced data to visualize maps to help citizens and public health agencies identify current and potential hotspots for the recent pandemic coronavirus, COVID-19. The project is a sister tool of Flu Near You, created by Ending Pandemics and Boston Children’s Hospital in 2012 and maintained by the Boston Children’s Hospital team.
                                                           
Media Contact:
Sandra Gharib
Sandrag@surveymonkey.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.